Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast ...
A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer - ...
Researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor 2-positive, estrogen ...
The warning comes amid reports that unregulated therapies are being offered directly to patients, potentially illegally.View ...
GlobalData on MSN6d
Unsafe and unregulated cell therapies being sold in EuropeThe EMA warns of products being sold as dendritic cell therapies with little evidence, but high health risks, in the European ...
Moffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer. The innovative approach targets human epidermal growth factor receptor ...
The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.
News-Medical.Net on MSN2d
Moffitt researchers discover new vaccine strategy for treating specific type of breast cancerMoffitt Cancer Center researchers have discovered a promising new vaccine strategy for treating a specific type of breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback